{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:30:11Z","timestamp":1789821011777,"version":"4.0.1"},"reference-count":50,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.3233\/jhd-180292","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T12:14:56Z","timestamp":1527855296000},"page":"101-108","source":"Crossref","is-referenced-by-count":19,"title":["A Fresh Look at Huntingtin mRNA Processing in Huntington\u2019s Disease"],"prefix":"10.1177","volume":"7","author":[{"given":"Lindsay","family":"Romo","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Mohn","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Aronin","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-180292_ref1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: An alternative approach to Huntington\u2019s disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JHD-180292_ref2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol Rev"},{"key":"10.3233\/JHD-180292_ref3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: Interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.3233\/JHD-180292_ref4","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/mds.26020","article-title":"Huntingtin-lowering strategies in Huntington\u2019s disease: Antisense oligonucleotides, small RNAs, and gene editing","volume":"29","author":"Aronin","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-180292_ref5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/wrna.1206","article-title":"Means to an end: Mechanisms of alternative polyadenylation of messenger RNA precursors","volume":"5","author":"Gruber","year":"2014","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.3233\/JHD-180292_ref6","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1093\/nar\/18.19.5799","article-title":"Point mutations in AAUAAA and the poly(A) addition site: Effects on the accuracy and efficiency of cleavage and polyadenylation in vitro","volume":"18","author":"Sheets","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.3233\/JHD-180292_ref7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/252359a0","article-title":"Sequence at the 3\u2019end of globin mRNA shows homology with immunoglobulin light chain mRNA","volume":"252","author":"Proudfoot","year":"1974","journal-title":"Nature"},{"key":"10.3233\/JHD-180292_ref8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1101\/gad.17268411","article-title":"Ending the message: Poly (A) signals then and now","volume":"25","author":"Proudfoot","year":"2011","journal-title":"Genes Dev"},{"key":"10.3233\/JHD-180292_ref9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1101\/gr.132563.111","article-title":"A quantitative atlas of polyadenylation in five mammals","volume":"22","author":"Derti","year":"2012","journal-title":"Genome Res"},{"key":"10.3233\/JHD-180292_ref10","doi-asserted-by":"crossref","unstructured":"Shi Y . Alternative polyadenylation: New insights from global analyses. 2012:2105\u201317.","DOI":"10.1261\/rna.035899.112"},{"key":"10.3233\/JHD-180292_ref11","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1523\/JNEUROSCI.2352-16.2016","article-title":"Dysregulation of mRNA localization and translation in genetic disease","volume":"36","author":"Wang","year":"2016","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-180292_ref12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0955-0674(92)90128-Y","article-title":"Determinants of mRNA localization","volume":"4","author":"Kislauskis","year":"1992","journal-title":"Curr Opin Cell Biol"},{"key":"10.3233\/JHD-180292_ref13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tcb.2009.06.001","article-title":"To localize or not to localize: mRNA fate is in 3\u2032UTR ends","volume":"19","author":"Andreassi","year":"2009","journal-title":"Trends Cell Biol"},{"key":"10.3233\/JHD-180292_ref14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cell.2008.05.045","article-title":"Distinct role of long 3\u2019 UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons","volume":"134","author":"An","year":"2008","journal-title":"Cell"},{"key":"10.3233\/JHD-180292_ref15","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1471-4159.2010.07016.x","article-title":"Involvement of the 3\u2019-untranslated region of the brain-derived neurotrophic factor gene in activity-dependent mRNA stabilization","volume":"115","author":"Fukuchi","year":"2010","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-180292_ref16","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1371\/journal.pcbi.0020043","article-title":"Differential repression of alternative transcripts: A screen for miRNA targets","volume":"2","author":"Legendre","year":"2006","journal-title":"PLoS Comput Biol"},{"key":"10.3233\/JHD-180292_ref17","doi-asserted-by":"crossref","first-page":"a012245","DOI":"10.1101\/cshperspect.a012245","article-title":"From cis-regulatory elements to complex RNPs and back","volume":"4","author":"Gebauer","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.3233\/JHD-180292_ref18","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1155390","article-title":"Proliferating cells express mRNAs with shortened 3\u2019 untranslated regions and fewer microRNA target sites","volume":"320","author":"Sandberg","year":"2008","journal-title":"Science"},{"key":"10.3233\/JHD-180292_ref19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/bfgp\/els056","article-title":"Translational control by 3\u2019-UTR-binding proteins","volume":"12","author":"Szostak","year":"2013","journal-title":"Brief Funct Genomics"},{"key":"10.3233\/JHD-180292_ref20","doi-asserted-by":"crossref","first-page":"e1004684","DOI":"10.1371\/journal.pgen.1004684","article-title":"Systematic analysis of the role of RNA-binding proteins in the regulation of RNA stability","volume":"10","author":"Hasan","journal-title":"PLoS Genet"},{"key":"10.3233\/JHD-180292_ref21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ceb.2012.12.008","article-title":"All\u2019s well that ends well: Alternative polyadenylation and its implications for stem cell biology","volume":"25","author":"Mueller","year":"2013","journal-title":"Curr Opin Cell Biol"},{"key":"10.3233\/JHD-180292_ref22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/hmg\/2.10.1541","article-title":"Differential 3\u2019 polyadenylation of the huntington disease gene results in two mRNA species with variable tissue expression","volume":"2","author":"Lin","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-180292_ref23","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1016\/j.celrep.2017.09.009","article-title":"Alterations in mRNA 3\u2032UTR isoform abundance accompany gene expression changes in human Huntington\u2019s disease brains","volume":"20","author":"Romo","year":"2017","journal-title":"Cell Rep"},{"key":"10.3233\/JHD-180292_ref24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington\u2019s disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-180292_ref25","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/brain\/awq047","article-title":"Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington\u2019s disease","volume":"133","author":"Thu","year":"2010","journal-title":"Brain"},{"key":"10.3233\/JHD-180292_ref26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntinqton\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-180292_ref27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","article-title":"Degeneration of the cerebellum in huntingtons disease (HD): Possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process","volume":"23","author":"R\u00fcb","year":"2013","journal-title":"Brain Pathol"},{"key":"10.3233\/JHD-180292_ref28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1371\/journal.pone.0076777","article-title":"Two functional variants of IRF5 influence the development of macular edema in patients with non-anterior uveitis","volume":"8","author":"M\u00e1rquez","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JHD-180292_ref29","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ncomms2032","article-title":"Alternative \u03b1-synuclein transcript usage as a convergent mechanism in Parkinson\u2019s disease pathology","volume":"3","author":"Rhinn","year":"2012","journal-title":"Nat Commun"},{"key":"10.3233\/JHD-180292_ref30","first-page":"1","article-title":"Distinct cellular toxicity of two mutant huntingtin mRNA variants due to translation regulation","author":"Xu","year":"2017","journal-title":"PLoS One"},{"key":"10.3233\/JHD-180292_ref31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","article-title":"Mechanisms and regulation of alternative pre-mRNA splicing","volume":"84","author":"Lee","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"10.3233\/JHD-180292_ref32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/15476286.2015.1112490","article-title":"From polyadenylation to splicing: Dual role for mRNA 3\u2019 end formation factors","volume":"13","author":"Misra","year":"2016","journal-title":"RNA Biol"},{"key":"10.3233\/JHD-180292_ref33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molcel.2015.03.016","article-title":"Global promotion of alternative internal exon usage by mRNA 3\u2019 end formation factors","volume":"58","author":"Misra","year":"2014","journal-title":"Mol Cell"},{"key":"10.3233\/JHD-180292_ref34","first-page":"1455","article-title":"Competitive regulation of alternative splicing and alternative polyadenylation by hnRNP H and CstF64 determines acetylcholinesterase isoforms","volume":"45","author":"Nazim","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.3233\/JHD-180292_ref35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mcn.2007.08.011","article-title":"BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae","volume":"37","author":"Chiaruttini","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.3233\/JHD-180292_ref36","doi-asserted-by":"crossref","first-page":"e0141298","DOI":"10.1371\/journal.pone.0141298","article-title":"Evidence of extensive alternative splicing in post mortem human brain HTT transcription by mRNA sequencing","volume":"10","author":"Labadorf","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JHD-180292_ref37","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jmb.2013.12.028","article-title":"Identification of novel alternative splicing events in the huntingtin gene and assessment of the functional consequences using structural protein homology modelling","volume":"426","author":"Hughes","year":"2014","journal-title":"J Mol Biol"},{"key":"10.3233\/JHD-180292_ref38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/hmg\/3.1.85","article-title":"Sequence of the murine Huntington disease gene: Evidence for conservation, alternate splicing and polymorphism in a triplet (CCG) repeat [corrected]","volume":"3","author":"Lin","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-180292_ref39","doi-asserted-by":"crossref","first-page":"e0127687","DOI":"10.1371\/journal.pone.0127687","article-title":"Discovery of novel isoforms of Huntingtin reveals a new hominid-specific exon","volume":"10","author":"Ruzo","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JHD-180292_ref40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JHD-150151","article-title":"Huntingtin exists as multiple splice forms in human brain","volume":"4","author":"Mort","year":"2015","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-180292_ref41","doi-asserted-by":"crossref","first-page":"8938","DOI":"10.1093\/nar\/gkr608","article-title":"CAG repeats mimic CUG repeats in the misregulation of alternative splicing","volume":"39","author":"Mykowska","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.3233\/JHD-180292_ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddw187","article-title":"Transcriptome sequencing reveals aberrant alternative splicing in Huntington\u2019s disease","volume":"25","author":"Lin","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-180292_ref43","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neuron.2015.01.008","article-title":"N17 modifies mutant huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice","volume":"85","author":"Gu","year":"2015","journal-title":"Neuron"},{"issue":"Suppl 1","key":"10.3233\/JHD-180292_ref44","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/01.wad.0000183082.76820.81","article-title":"Tau alternative splicing and frontotemporal dementia","volume":"19","author":"Kar","year":"2005","journal-title":"Tau alternative splicing and frontotemporal dementia. Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JHD-180292_ref45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.3233\/JHD-180292_ref46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s100480050021","article-title":"Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7","volume":"1","author":"Rochette","year":"1997","journal-title":"Neurogenetics"},{"key":"10.3233\/JHD-180292_ref47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.1884910","article-title":"A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity service A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity","author":"Cho","year":"2010","journal-title":"Genes Dev"},{"key":"10.3233\/JHD-180292_ref48","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-180292_ref49","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4161\/rna.26706","article-title":"Aberrantly spliced HTT, a new player in Huntington\u2019s disease pathogenesis","volume":"10","author":"Gipson","year":"2013","journal-title":"RNA Biol"},{"key":"10.3233\/JHD-180292_ref50","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/s41598-017-01510-z","article-title":"The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients","volume":"7","author":"Neueder","year":"2017","journal-title":"Sci Rep"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-180292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:26Z","timestamp":1777453046000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-180292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":50,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jhd-180292","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}